BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 12465066)

  • 21. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
    Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
    Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET].
    Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Higano S; Fujita H; Shimosegawa E; Kanno I; Aizawa Y
    Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
    Chun K; Kong E; Cho I
    Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
    Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
    Clin Neurol Neurosurg; 2009 Dec; 111(10):829-34. PubMed ID: 19735974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
    Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
    Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
    J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.
    Varrone A; Pagani M; Salvatore E; Salmaso D; Sansone V; Amboni M; Nobili F; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1071-81. PubMed ID: 17245531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study.
    Cilia R; Marotta G; Landi A; Isaias IU; Vergani F; Benti R; Sganzerla E; Gerundini P; Pezzoli G; Antonini A
    Eur J Neurol; 2008 Jan; 15(1):22-8. PubMed ID: 18042244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.
    El Fakhri G; Habert MO; Maksud P; Kas A; Malek Z; Kijewski MF; Lacomblez L
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):87-92. PubMed ID: 16180033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain SPECT imaging in multiple system atrophy.
    Cilia R; Marotta G; Benti R; Pezzoli G; Antonini A
    J Neural Transm (Vienna); 2005 Dec; 112(12):1635-45. PubMed ID: 16284908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings.
    Chen JJ; Yen RF; Kao A; Lin CC; Lee CC
    Clin Rheumatol; 2002 Nov; 21(6):516-9. PubMed ID: 12447638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical application value of brain
    Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
    [No Abstract]   [Full Text] [Related]  

  • 40. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.